Previous Statements by GERN
» Geron CEO Discusses Q3 2010 Results - Earnings Call Transcript
» Geron Corporation Q2 2010 Earnings Call Transcript
» Geron Corporation Q1 2010 Earnings Call Transcript
Geron (GERN) announced on Monday that it agreed to a licensing deal with Janssen Pharmaceuticals worth $80 million.
Trade-Ideas LLC identified Geron (GERN) as a strong on high relative volume candidate